Washington University Develops Enzyme Method for ALS, Parkinson's Potential
Researchers at Washington University in St. Louis have announced the development of a new method to rapidly produce and screen disaggregase enzymes. These enzymes are capable of breaking down misfolded proteins, which are associated with neurodegenerative conditions such as ALS and Parkinson's disease. This scientific advance holds potential for future treatment development against these debilitating illnesses.
Researchers at Washington University in St. Louis have developed a novel method with potential implications for treating neurodegenerative diseases. The team, led by Meredith Jackrel, an associate professor of chemistry in Arts & Sciences, focused on advancing the study of specific enzymes.
The developed method enables the rapid production and screening of a class of disaggregase enzymes. These enzymes are known for their ability to break down misfolded proteins within the body. Misfolded proteins are a key factor in the progression of several neurodegenerative conditions.
This scientific breakthrough specifically targets proteins associated with Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease. The long-term goal of this research is to contribute to the development of new treatments for these debilitating diseases.
According to Phys.org, this advance could one day lead to new therapeutic options.
Advertisement
AdSense slot • inline
